SAREUM HOLDINGS PLC Logo

SAREUM HOLDINGS PLC

Clinical-stage company developing kinase inhibitors for autoimmune diseases and cancer.

SAR | IL

Overview

Corporate Details

ISIN(s):
GB00BMC3RJ87
LEI:
213800PKERN2DY8FFM72
Country:
United Kingdom
Address:
UNIT 2A, CB22 3FX CAMBRIDGE

Description

Sareum Holdings PLC is a clinical-stage small molecule company that discovers and develops next-generation kinase inhibitors for the treatment of autoimmune diseases and cancer. The company's research is primarily focused on the TYK/JAK kinase cell signalling family, with a specific emphasis on developing dual inhibitors of TYK2 and JAK1. This approach is pursued for its potential to offer superior efficacy compared to agents that target only one of these kinases. Its development pipeline includes SDC-1801, a potential oral therapy for autoimmune diseases, as well as other programs targeting cancer and viral infections.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-07-01 08:00
Covid-19 Research Project Results
English 14.4 KB
2021-06-24 15:05
Second Price Monitoring Extn
English 2.9 KB
2021-06-24 15:00
Price Monitoring Extension
English 2.9 KB
2021-06-21 09:00
Sareum to Present at BioTrinity 2021 Conference
English 11.1 KB
2021-06-17 17:40
Second Price Monitoring Extn
English 2.8 KB
2021-06-17 17:35
Price Monitoring Extension
English 2.8 KB
2021-06-17 12:05
Second Price Monitoring Extn
English 2.8 KB
2021-06-17 12:00
Price Monitoring Extension
English 2.8 KB
2021-06-16 15:05
Second Price Monitoring Extn
English 2.8 KB
2021-06-16 15:00
Price Monitoring Extension
English 2.8 KB
2021-06-16 10:06
Second Price Monitoring Extn
English 2.8 KB
2021-06-16 10:00
Price Monitoring Extension
English 2.8 KB
2021-06-15 12:19
Subscription to raise £1,470,000
English 13.7 KB
2021-06-14 17:40
Second Price Monitoring Extn
English 2.8 KB
2021-06-14 17:35
Price Monitoring Extension
English 2.8 KB

Automate Your Workflow. Get a real-time feed of all SAREUM HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SAREUM HOLDINGS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SAREUM HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.